Sonoma Pharmaceuticals
SNOA
$0.16
Share price
2.03%
Change (1 day)
-83.57%
Change (1 year)
Categories
P/S ratio for Sonoma Pharmaceuticals (SNOA)
P/S ratio as of May 2024 (TTM): 0.1941
According to Sonoma Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.19411. At the end of 2023 the company had a P/S ratio of 0.2005.
P/S ratio history for Sonoma Pharmaceuticals from 2007 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.2005 | -27.64% |
| 2022 | 0.2771 | -75.52% |
| 2021 | 1.13 | 57.85% |
| 2020 | 0.7170 | 66.53% |
| 2019 | 0.4306 | -7.92% |
| 2018 | 0.4676 | -66.82% |
| 2017 | 1.41 | -18.18% |
| 2016 | 1.72 | 22.6% |
| 2015 | 1.40 | 45.05% |
| 2014 | 0.9685 | -45.84% |
| 2013 | 1.79 | 21.43% |
| 2012 | 1.47 | -36.9% |
| 2011 | 2.33 | -51.6% |
| 2010 | 4.82 | -30.09% |
| 2009 | 6.90 | 104.31% |
| 2008 | 3.38 | -70.66% |
| 2007 | 11.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | 440.59% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 47,552.67% | 🇺🇸 USA |